Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

NCT03500367 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Uterine Fibroids

Interventions

DRUG: rapamycin

Sponsor

Peking Union Medical College Hospital